| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | MTA2 NCOA6 SREBF1 SREBF2 POU4F1 SIRT7 CBFA2T3 HDAC7 TFAP2B DDX11 TNRC18 MLH3 MTA3 SCMH1 ATAD2B MITF PAX3 TOX2 EP300 NOTCH1 KDM1A | 1.49e-06 | 739 | 171 | 21 | GO:0003682 |
| GeneOntologyBiologicalProcess | developmental growth | WDR36 RAPH1 COX10 TNS2 SPG11 STIL SIX4 ADARB1 KIAA0319 TTC8 ALMS1 DIO3 COBL MST1L ATM SMPD3 STK40 TBX20 EP300 MUSK NOTCH1 KDM1A | 5.08e-06 | 911 | 168 | 22 | GO:0048589 |
| GeneOntologyBiologicalProcess | multicellular organism growth | COX10 TNS2 STIL ADARB1 TTC8 ALMS1 DIO3 ATM SMPD3 STK40 EP300 | 6.49e-06 | 249 | 168 | 11 | GO:0035264 |
| GeneOntologyBiologicalProcess | somite development | 1.18e-05 | 94 | 168 | 7 | GO:0061053 | |
| GeneOntologyBiologicalProcess | central nervous system development | NCOA6 DLG5 DMXL2 KLHL1 ARHGEF28 GRID2 POU4F1 SPG11 STIL ADARB1 NR2F1 TTC8 FOXB1 PTPRZ1 CSNK1D SPHK1 NAV2 SDF4 PAX3 ATM TACC3 TBX20 BAG6 NOTCH1 KDM1A | 1.37e-05 | 1197 | 168 | 25 | GO:0007417 |
| GeneOntologyBiologicalProcess | neuron projection development | DLG5 KLHL1 ARHGEF28 WDR36 RAPH1 GRID2 POU4F1 SPG11 ADARB1 NR2F1 KIAA0319 TTC8 FOXB1 CELSR3 ALMS1 LZTS1 PTPRZ1 SPHK1 CSPG4 COBL CDC20 PARD3 EP300 MUSK NOTCH1 KDM1A | 1.57e-05 | 1285 | 168 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | DLG5 KLHL1 ARHGEF28 WDR36 RAPH1 GRID2 POU4F1 SPG11 PCDH12 ADARB1 NR2F1 KIAA0319 TTC8 FOXB1 CELSR3 ALMS1 LZTS1 PTPRZ1 SPHK1 CSPG4 DIO3 COBL CDC20 PARD3 EP300 MUSK NOTCH1 KDM1A | 1.96e-05 | 1463 | 168 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | somitogenesis | 3.64e-05 | 76 | 168 | 6 | GO:0001756 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | MTA2 RALGAPA1 ZHX3 NR2C1 SREBF1 SREBF2 POU4F1 SIRT7 CBFA2T3 HDAC7 TFAP2B NR2F1 LPIN1 FOXD3 MTA3 MITF HES6 PAX3 TBX20 EP300 NOTCH1 KDM1A | 4.72e-05 | 1053 | 168 | 22 | GO:0000122 |
| GeneOntologyBiologicalProcess | head development | NCOA6 DLG5 DMXL2 KLHL1 GRID2 POU4F1 STIL NR2F1 TTC8 FOXB1 CSNK1D SPHK1 NAV2 SDF4 ATM TACC3 BAG6 EP300 NOTCH1 KDM1A | 6.13e-05 | 919 | 168 | 20 | GO:0060322 |
| GeneOntologyBiologicalProcess | axonogenesis | ARHGEF28 WDR36 RAPH1 POU4F1 SPG11 ADARB1 KIAA0319 TTC8 FOXB1 CELSR3 PTPRZ1 COBL PARD3 EP300 NOTCH1 | 6.36e-05 | 566 | 168 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | MTA2 RALGAPA1 ZHX3 NR2C1 DUSP5 SREBF1 SREBF2 POU4F1 SIRT7 SIX4 CBFA2T3 HDAC7 TFAP2B NR2F1 LPIN1 FOXD3 MTA3 SCMH1 MITF HES6 CDY2A PAX3 TBX20 EP300 NOTCH1 KDM1A | 6.60e-05 | 1399 | 168 | 26 | GO:0045892 |
| GeneOntologyBiologicalProcess | segmentation | 6.75e-05 | 123 | 168 | 7 | GO:0035282 | |
| GeneOntologyBiologicalProcess | brain development | NCOA6 DLG5 DMXL2 KLHL1 GRID2 POU4F1 STIL NR2F1 TTC8 FOXB1 CSNK1D SPHK1 NAV2 SDF4 ATM TACC3 BAG6 NOTCH1 KDM1A | 7.66e-05 | 859 | 168 | 19 | GO:0007420 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MTA2 RALGAPA1 ZHX3 NR2C1 DUSP5 SREBF1 SREBF2 POU4F1 SIRT7 SIX4 CBFA2T3 HDAC7 TFAP2B NR2F1 LPIN1 FOXD3 MTA3 SCMH1 MITF HES6 CDY2A PAX3 TBX20 EP300 NOTCH1 KDM1A | 7.77e-05 | 1413 | 168 | 26 | GO:1902679 |
| GeneOntologyBiologicalProcess | floor plate development | 8.35e-05 | 11 | 168 | 3 | GO:0033504 | |
| GeneOntologyBiologicalProcess | pattern specification process | STIL NR2F1 TTC8 FOXB1 SCMH1 PCSK6 DCHS1 COBL HES6 PAX3 ATM TBX20 EP300 NOTCH1 | 1.07e-04 | 526 | 168 | 14 | GO:0007389 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | DLG5 POU4F1 STIL SIX4 ADARB1 TGFB1I1 GREB1L TTC8 ALMS1 PHACTR4 DCHS1 COBL PAX3 MST1L PARD3 TBX20 NOTCH1 | 1.39e-04 | 750 | 168 | 17 | GO:0048729 |
| GeneOntologyBiologicalProcess | collecting duct development | 1.43e-04 | 13 | 168 | 3 | GO:0072044 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | DLG5 STIL SIX4 TGFB1I1 GREB1L TTC8 ALMS1 PHACTR4 DCHS1 COBL PAX3 MST1L PARD3 TBX20 NOTCH1 | 1.71e-04 | 619 | 168 | 15 | GO:0002009 |
| GeneOntologyBiologicalProcess | growth | WDR36 RAPH1 COX10 TNS2 SPG11 STIL SIX4 ADARB1 KIAA0319 TTC8 ALMS1 SPHK1 DIO3 COBL MST1L ATM SMPD3 STK40 TBX20 EP300 MUSK NOTCH1 KDM1A | 1.76e-04 | 1235 | 168 | 23 | GO:0040007 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | WDR36 RAPH1 SPG11 SIX4 KIAA0319 COBL MST1L EP300 NOTCH1 KDM1A | 1.77e-04 | 299 | 168 | 10 | GO:0060560 |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 1.98e-04 | 247 | 168 | 9 | GO:0009952 | |
| GeneOntologyBiologicalProcess | axon development | ARHGEF28 WDR36 RAPH1 POU4F1 SPG11 ADARB1 KIAA0319 TTC8 FOXB1 CELSR3 PTPRZ1 COBL PARD3 EP300 NOTCH1 | 2.52e-04 | 642 | 168 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ARHGEF28 WDR36 RAPH1 POU4F1 SPG11 ADARB1 KIAA0319 TTC8 FOXB1 CELSR3 LZTS1 PTPRZ1 COBL PARD3 EP300 NOTCH1 KDM1A | 3.06e-04 | 802 | 168 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | heart valve formation | 3.32e-04 | 17 | 168 | 3 | GO:0003188 | |
| GeneOntologyBiologicalProcess | renal tubule development | 3.78e-04 | 116 | 168 | 6 | GO:0061326 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ARHGEF28 WDR36 RAPH1 POU4F1 SPG11 ADARB1 KIAA0319 TTC8 FOXB1 CELSR3 LZTS1 PTPRZ1 COBL PARD3 EP300 NOTCH1 KDM1A | 3.89e-04 | 819 | 168 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell migration involved in endocardial cushion formation | 3.91e-04 | 4 | 168 | 2 | GO:0003273 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGEF28 WDR36 RAPH1 POU4F1 SPG11 ADARB1 KIAA0319 TTC8 FOXB1 CELSR3 LZTS1 PTPRZ1 COBL PARD3 EP300 NOTCH1 | 4.18e-04 | 748 | 168 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ARHGEF28 WDR36 RAPH1 POU4F1 SPG11 ADARB1 KIAA0319 TTC8 FOXB1 CELSR3 LZTS1 PTPRZ1 COBL PARD3 EP300 NOTCH1 KDM1A | 4.28e-04 | 826 | 168 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | tube development | DLG5 SREBF1 STIL SIX4 HDAC7 TFAP2B GREB1L TTC8 FOXB1 SPHK1 CSPG4 PHACTR4 DCHS1 COBL PAX3 MST1L SMPD3 STK40 AMOTL2 TBX20 BAG6 EP300 NOTCH1 EPHA1 | 4.38e-04 | 1402 | 168 | 24 | GO:0035295 |
| Domain | Cobl | 7.95e-05 | 2 | 167 | 2 | PF09469 | |
| Domain | Cordon-bleu_ubiquitin_domain | 7.95e-05 | 2 | 167 | 2 | IPR019025 | |
| Domain | ATM/Tel1 | 7.95e-05 | 2 | 167 | 2 | IPR015519 | |
| Domain | BAH | 1.10e-04 | 11 | 167 | 3 | PS51038 | |
| Domain | BAH_dom | 1.10e-04 | 11 | 167 | 3 | IPR001025 | |
| Domain | BAH | 1.10e-04 | 11 | 167 | 3 | SM00439 | |
| Domain | BAH | 1.10e-04 | 11 | 167 | 3 | PF01426 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 NCOA6 DLG5 ARHGEF28 RAPH1 PPFIA1 COBLL1 SIPA1L3 RAB11FIP2 USP43 PLEKHG2 STIL EDC4 HDAC7 GAB2 CEP170 MDN1 ALMS1 CSNK1D SYDE2 PHACTR4 NAV2 COBL CRYBG3 CDC20 PARD3 MUSK | 3.61e-14 | 861 | 175 | 27 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 MTA2 NCOA6 SIPA1L3 DUSP5 HECTD4 SREBF1 EDC4 ITGB4 HDAC7 MFSD12 PCNX2 SLC7A1 TNRC18 MDN1 CELSR3 ZNF592 KCNH2 SPHK1 CSPG4 NAV2 COBL HES6 SDF4 STK40 AP3D1 EP300 NOTCH1 | 2.01e-12 | 1105 | 175 | 28 | 35748872 |
| Pubmed | MTA2 NCOA6 RAPH1 HEATR1 EDC4 TUFM CEP170 ALMS1 ANAPC1 PHACTR4 TACC3 AMOTL2 PARD3 EP300 KDM1A TP53BP1 RGPD5 | 3.15e-09 | 549 | 175 | 17 | 38280479 | |
| Pubmed | RALGAPA1 SMG1 NCOA6 DLG5 HECTD4 SPG11 CAMKK2 CELSR3 MTA3 ZNF592 NAV2 AMOTL2 BSN KDM1A AGAP1 | 8.71e-08 | 529 | 175 | 15 | 14621295 | |
| Pubmed | DMXL2 RGPD8 HCN4 PPFIA1 SIPA1L3 HECTD4 EDC4 KIAA0319 CEP170 MDN1 ANAPC1 LZTS1 DCHS1 ANKRD28 TACC3 BSN PARD3 PPP6R2 KDM1A TP53BP1 | 9.78e-08 | 963 | 175 | 20 | 28671696 | |
| Pubmed | Extracellular matrix mechanical cues regulate lipid metabolism through Lipin-1 and SREBP. | 1.25e-07 | 3 | 175 | 3 | 30718857 | |
| Pubmed | SMG1 CDC42BPG DMXL2 ARHGEF28 ARHGAP23 SREBF1 SREBF2 MFSD12 TUFM DOCK5 LPIN1 MARF1 ANKRD28 CRYBG3 PPP6R2 AP3D1 | 2.16e-07 | 650 | 175 | 16 | 38777146 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RALGAPA1 PPFIA1 USP43 DOCK5 SLC7A1 LNPEP CSPG4 PHACTR4 NAV2 COBL PARD3 FAM135A NOTCH1 EPHA1 AGAP1 | 2.22e-07 | 569 | 175 | 15 | 30639242 |
| Pubmed | NR2C1 RGPD8 RAPH1 PPFIA1 GREB1L NOL4L ALMS1 ZNF592 ANAPC1 ANKRD28 CRYBG3 TACC3 KDM1A | 2.30e-07 | 418 | 175 | 13 | 34709266 | |
| Pubmed | Neogenin-loss in neural crest cells results in persistent hyperplastic primary vitreous formation. | 2.97e-07 | 12 | 175 | 4 | 31336386 | |
| Pubmed | RALGAPA1 PPFIA1 SIPA1L3 RAB11FIP2 HDAC7 CEP170 ALMS1 ANAPC1 ANKRD28 AMOTL2 PARD3 PPP6R2 NOTCH1 | 4.78e-07 | 446 | 175 | 13 | 24255178 | |
| Pubmed | RALGAPA1 DLG5 DMXL2 ATP6V0A1 WDR36 PDE7A PPFIA1 SPG11 HEATR1 UBE4A CAMKK2 MDN1 LNPEP PHACTR4 ANKRD28 SDF4 ATM CRYBG3 PARD3 PPP6R2 FAM135A BAG6 AP3D1 TP53BP1 | 4.95e-07 | 1487 | 175 | 24 | 33957083 | |
| Pubmed | SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. | 4.99e-07 | 4 | 175 | 3 | 8918891 | |
| Pubmed | mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. | 4.99e-07 | 4 | 175 | 3 | 21816276 | |
| Pubmed | MTA2 ZHX3 NCOA6 DLG5 WDR36 RAPH1 HEATR1 SIX4 TUFM CEP170 CRYBG3 TACC3 TP53BP1 | 9.01e-07 | 472 | 175 | 13 | 38943005 | |
| Pubmed | JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phase. | 1.08e-06 | 16 | 175 | 4 | 26291670 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ZHX3 PPFIA1 CCDC187 SPG11 MDN1 ZNF592 NAV2 COBL ANKRD28 ATM BAG6 AP3D1 KDM1A | 1.59e-06 | 497 | 175 | 13 | 36774506 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HEATR1 SIX4 CBFA2T3 NR2F1 UBE4A FOXD3 FOXB1 PRDM10 MDN1 ANAPC1 ANKRD28 PAX3 STK40 EP300 NOTCH1 KDM1A TP53BP1 | 1.76e-06 | 857 | 175 | 17 | 25609649 |
| Pubmed | 2.30e-06 | 225 | 175 | 9 | 12168954 | ||
| Pubmed | MTA2 ARHGAP23 PPFIA1 TAF1C TUFM CEP170 MLH3 ALMS1 MTA3 ZNF592 ANAPC1 TRIM56 PCSK6 ANKRD28 SDF4 CRYBG3 PARD3 EP300 KDM1A | 3.95e-06 | 1116 | 175 | 19 | 31753913 | |
| Pubmed | 5.09e-06 | 23 | 175 | 4 | 14522948 | ||
| Pubmed | MTA2 WDR36 HEATR1 SIRT7 EDC4 TUFM CEP170 MDN1 ANAPC1 ATAD2B ANKRD28 ATM KDM1A TP53BP1 | 6.26e-06 | 653 | 175 | 14 | 22586326 | |
| Pubmed | 6.54e-06 | 52 | 175 | 5 | 9455477 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 NCOA6 RAPH1 ADARB1 HDAC7 NOL4L MDN1 ZNF592 ANAPC1 PHACTR4 ATM TACC3 PARD3 BAG6 TP53BP1 | 9.66e-06 | 774 | 175 | 15 | 15302935 |
| Pubmed | WDR36 PPFIA1 MUC16 TUFM GAB2 DOCK5 SYDE2 PHACTR4 ANKRD28 TACC3 PARD3 FAM135A SPTY2D1 AP3D1 AGAP1 | 1.01e-05 | 777 | 175 | 15 | 35844135 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | MTA2 TAF1C SREBF1 SREBF2 POU4F1 TFAP2B TGFB1I1 PCBD2 FOXB1 ZNF592 SCMH1 MITF HES6 PAX3 TBX20 EP300 | 1.02e-05 | 877 | 175 | 16 | 20211142 |
| Pubmed | The histone demethylase LSD1/KDM1A promotes the DNA damage response. | 1.03e-05 | 9 | 175 | 3 | 24217620 | |
| Pubmed | 1.03e-05 | 9 | 175 | 3 | 9767163 | ||
| Pubmed | 1.17e-05 | 209 | 175 | 8 | 36779422 | ||
| Pubmed | ZHX3 PPFIA1 NOXA1 SREBF1 TNS2 OAZ1 ITGB4 TGFB1I1 NUTM2B SCMH1 PPP6R2 BAG6 NOTCH1 | 1.39e-05 | 608 | 175 | 13 | 16713569 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.46e-05 | 10 | 175 | 3 | 20664521 | |
| Pubmed | 1.46e-05 | 10 | 175 | 3 | 15314156 | ||
| Pubmed | Six1 and Six4 promote survival of sensory neurons during early trigeminal gangliogenesis. | 1.46e-05 | 10 | 175 | 3 | 16938278 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.72e-05 | 289 | 175 | 9 | 23752268 | |
| Pubmed | Activator-Mediator binding regulates Mediator-cofactor interactions. | 2.01e-05 | 11 | 175 | 3 | 20534441 | |
| Pubmed | MTA2 DLG5 WDR36 PPFIA1 TAF1C COBLL1 SIPA1L3 SIRT7 TUFM CEP170 CSNK1D TRIM56 PCSK6 MARF1 SDF4 CDC20 PARD3 SPTY2D1 AP3D1 MBNL3 | 2.08e-05 | 1371 | 175 | 20 | 36244648 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 CDC42BPG SIPA1L3 HECTD4 SREBF2 POMT1 ADARB1 ADGRG6 PCNX2 CEP170 DOCK5 TTC8 SLC7A1 TNRC18 MTA3 CSNK1D TTC12 COBL PARD3 EP300 AGAP1 | 2.10e-05 | 1489 | 175 | 21 | 28611215 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | NR2C1 SREBF1 SREBF2 POU4F1 SIX4 TFAP2B NR2F1 FOXD3 FOXB1 HES6 PAX3 TBX20 | 2.22e-05 | 544 | 175 | 12 | 28473536 |
| Pubmed | DLG5 WDR36 PPFIA1 TAF1C SIPA1L3 HEATR1 SIRT7 SIX4 EDC4 TUFM GREB1L MDN1 MTA3 ZNF592 ANAPC1 LNPEP TRIM56 PARD3 SPTY2D1 KDM1A AGAP1 | 2.27e-05 | 1497 | 175 | 21 | 31527615 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 20535152 | ||
| Pubmed | 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. | 2.52e-05 | 2 | 175 | 2 | 27613518 | |
| Pubmed | ATM and 53BP1 regulate alternative end joining-mediated V(D)J recombination. | 2.52e-05 | 2 | 175 | 2 | 39083600 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 27614840 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 15062879 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 31565865 | ||
| Pubmed | Analysis of the hotfoot (ho) locus by creation of an insertional mutation in a transgenic mouse. | 2.52e-05 | 2 | 175 | 2 | 1689261 | |
| Pubmed | Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. | 2.52e-05 | 2 | 175 | 2 | 12640139 | |
| Pubmed | Gads/Grb2-mediated association with LAT is critical for the inhibitory function of Gab2 in T cells. | 2.52e-05 | 2 | 175 | 2 | 12640133 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16275030 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 28367087 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16879892 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 26252164 | ||
| Pubmed | SREBP transcription factors: master regulators of lipid homeostasis. | 2.52e-05 | 2 | 175 | 2 | 15589694 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17310989 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16141315 | ||
| Pubmed | [Clinical and molecular genetic investigation of Waardenburg syndrome type 1]. | 2.52e-05 | 2 | 175 | 2 | 12666593 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11449275 | ||
| Pubmed | Mocha, a new coat color and behavior mutation on chromosome 10 of the mouse. | 2.52e-05 | 2 | 175 | 2 | 4448900 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 10585467 | ||
| Pubmed | hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress. | 2.52e-05 | 2 | 175 | 2 | 18332866 | |
| Pubmed | The absence of Grb2-associated binder 2 (Gab2) does not disrupt NK cell development and functions. | 2.52e-05 | 2 | 175 | 2 | 15240750 | |
| Pubmed | Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. | 2.52e-05 | 2 | 175 | 2 | 11231058 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9885561 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 35411035 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23858098 | ||
| Pubmed | Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. | 2.52e-05 | 2 | 175 | 2 | 9500554 | |
| Pubmed | Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. | 2.52e-05 | 2 | 175 | 2 | 11861309 | |
| Pubmed | PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression. | 2.52e-05 | 2 | 175 | 2 | 21164369 | |
| Pubmed | The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL. | 2.52e-05 | 2 | 175 | 2 | 26855418 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 32437087 | ||
| Pubmed | Acetylation of sphingosine kinase 1 regulates cell growth and cell-cycle progression. | 2.52e-05 | 2 | 175 | 2 | 22227192 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16369543 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 27282405 | ||
| Pubmed | Inhibition of MITF transcriptional activity independent of targeting p300/CBP coactivators. | 2.52e-05 | 2 | 175 | 2 | 17250547 | |
| Pubmed | SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair. | 2.52e-05 | 2 | 175 | 2 | 30944854 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 39226322 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16009726 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18936756 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 29449559 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 8402897 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 31490983 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23000402 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9412510 | ||
| Pubmed | Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells. | 2.52e-05 | 2 | 175 | 2 | 33744762 | |
| Pubmed | Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. | 2.52e-05 | 2 | 175 | 2 | 11042216 | |
| Pubmed | P300 binds to and acetylates MTA2 to promote colorectal cancer cells growth. | 2.52e-05 | 2 | 175 | 2 | 24468085 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 7903453 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17921436 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9329978 | ||
| Pubmed | A non-canonical role for the EDC4 decapping factor in regulating MARF1-mediated mRNA decay. | 2.52e-05 | 2 | 175 | 2 | 32510323 | |
| Pubmed | Grb2 associated binder 2 couples B-cell receptor to cell survival. | 2.52e-05 | 2 | 175 | 2 | 18950707 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 27125306 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 37937666 | ||
| Pubmed | Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2). | 2.52e-05 | 2 | 175 | 2 | 9070916 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 18996087 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16046411 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 26773044 | ||
| Pubmed | Tbx20 controls the expression of the KCNH2 gene and of hERG channels. | 2.52e-05 | 2 | 175 | 2 | 28049825 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 36007472 | ||
| Pubmed | BAG6/BAT3 modulates autophagy by affecting EP300/p300 intracellular localization. | 2.52e-05 | 2 | 175 | 2 | 24852146 | |
| Interaction | YWHAH interactions | RALGAPA1 CDC42BPG NCOA6 DLG5 ARHGEF28 PPFIA1 COBLL1 SIPA1L3 RAB11FIP2 HECTD4 USP43 TNS2 PLEKHG2 STIL EDC4 HDAC7 GAB2 CEP170 ALMS1 CSNK1D KCNH2 SYDE2 PHACTR4 MITF NAV2 COBL CRYBG3 AMOTL2 CDC20 PARD3 AGAP1 | 3.41e-09 | 1102 | 171 | 31 | int:YWHAH |
| Interaction | YWHAG interactions | RALGAPA1 NCOA6 DLG5 ARHGEF28 RAPH1 ARHGAP23 PPFIA1 COBLL1 SIPA1L3 RAB11FIP2 HECTD4 USP43 TNS2 OAZ1 PLEKHG2 EDC4 HDAC7 GAB2 CEP170 LPIN1 MDN1 ALMS1 SYDE2 PHACTR4 MITF NAV2 COBL AMOTL2 CDC20 PARD3 AGAP1 | 6.03e-08 | 1248 | 171 | 31 | int:YWHAG |
| Interaction | WWTR1 interactions | MTA2 NCOA6 RAPH1 HEATR1 EDC4 CEP170 ALMS1 ANAPC1 PHACTR4 PAX3 TACC3 AMOTL2 PARD3 EP300 NOTCH1 TP53BP1 RGPD5 | 1.23e-07 | 422 | 171 | 17 | int:WWTR1 |
| Interaction | TOP3B interactions | VWA5B2 MTA2 NCOA6 WDR36 SIPA1L3 DUSP5 HECTD4 SREBF1 EDC4 ITGB4 HDAC7 MFSD12 TUFM PCNX2 SLC7A1 TNRC18 MDN1 CELSR3 ZNF592 KCNH2 SPHK1 TRIM56 CSPG4 NAV2 COBL HES6 SDF4 STK40 AP3D1 EP300 NOTCH1 TP53BP1 | 7.00e-07 | 1470 | 171 | 32 | int:TOP3B |
| Interaction | DYRK1A interactions | RALGAPA1 DLG5 PPFIA1 SIPA1L3 TNS2 ITGB4 LPIN1 CAMKK2 MTA3 ANAPC1 LZTS1 LNPEP TRIM56 PCSK6 DCHS1 EP300 AGAP1 | 4.93e-06 | 552 | 171 | 17 | int:DYRK1A |
| Interaction | YWHAZ interactions | RALGAPA1 CDC42BPG DLG5 DMXL2 ARHGEF28 PDE7A RAPH1 PPFIA1 COBLL1 SIPA1L3 RAB11FIP2 HECTD4 USP43 HDAC7 TUFM GAB2 CEP170 CSNK1D SYDE2 PHACTR4 NAV2 ANKRD28 SDF4 ATM PARD3 EP300 TP53BP1 AGAP1 | 6.25e-06 | 1319 | 171 | 28 | int:YWHAZ |
| Interaction | RAC1 interactions | RALGAPA1 PRPSAP2 CDC42BPG DLG5 RAPH1 ARHGAP23 PPFIA1 SIPA1L3 NOXA1 PLEKHG2 HDAC7 ADGRG6 DOCK5 SLC7A1 MDN1 PLEKHG6 LNPEP SYDE2 PHACTR4 COBL PARD3 BAG6 NOTCH1 AGAP1 | 1.14e-05 | 1063 | 171 | 24 | int:RAC1 |
| Interaction | KDM1A interactions | MTA2 NR2C1 DLG5 RAPH1 PPFIA1 SIRT7 CBFA2T3 ADARB1 GREB1L NOL4L ALMS1 MTA3 ZNF592 ANAPC1 LZTS1 ANKRD28 CRYBG3 TACC3 EP300 NOTCH1 KDM1A TP53BP1 | 1.61e-05 | 941 | 171 | 22 | int:KDM1A |
| Interaction | YWHAB interactions | RALGAPA1 DLG5 ARHGEF28 PDE7A ARHGAP23 PPFIA1 COBLL1 SIPA1L3 RAB11FIP2 HECTD4 USP43 TNS2 ITGB4 HDAC7 GAB2 CEP170 SYDE2 PHACTR4 MITF NAV2 AMOTL2 PARD3 AGAP1 | 1.65e-05 | 1014 | 171 | 23 | int:YWHAB |
| Interaction | ENTR1 interactions | 3.36e-05 | 188 | 171 | 9 | int:ENTR1 | |
| Interaction | CDC42 interactions | RALGAPA1 PRPSAP2 CDC42BPG DLG5 ATP6V0A1 RAPH1 PPFIA1 COBLL1 HEATR1 PLEKHG2 EDC4 HDAC7 SLC7A1 MDN1 SCMH1 LNPEP CSPG4 PHACTR4 TTC12 COBL PARD3 FAM135A BAG6 AP3D1 NOTCH1 AGAP1 | 5.20e-05 | 1323 | 171 | 26 | int:CDC42 |
| Interaction | XRN1 interactions | VWA5B2 SREBF2 HEATR1 PLEKHG2 STIL SIRT7 EDC4 MARF1 BAG6 KDM1A | 7.37e-05 | 258 | 171 | 10 | int:XRN1 |
| Interaction | AMOT interactions | DLG5 PPFIA1 SIPA1L3 ALMS1 LZTS1 ANKRD28 CRYBG3 AMOTL2 PARD3 EP300 KDM1A | 7.54e-05 | 312 | 171 | 11 | int:AMOT |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.17e-05 | 206 | 115 | 8 | 682 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 5.92e-04 | 6 | 115 | 2 | 699 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 8.25e-04 | 7 | 115 | 2 | 917 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 SMG1 ZHX3 STIL PRDM10 ATAD2B PHACTR4 ATM TOX2 EP300 | 3.91e-07 | 180 | 175 | 10 | M8239 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | VWA5B2 STIL SIX4 DDX11 GREB1L TTC8 CELSR3 ALMS1 PTPRZ1 CPT1C ANKRD28 HES6 TACC3 CDC20 KDM1A TP53BP1 REV1 | 3.40e-06 | 680 | 175 | 17 | MM456 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 DMXL2 PPFIA1 DUSP5 SPG11 STIL ADARB1 ADGRG6 CEP170 SLC7A1 MDN1 NALF1 ATAD2B MITF ANKRD28 CRYBG3 PARD3 TP53BP1 AGAP1 | 4.95e-06 | 856 | 175 | 19 | M4500 |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_UP | 6.81e-06 | 147 | 175 | 8 | M2506 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-08 | 172 | 175 | 9 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.54e-08 | 186 | 175 | 9 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.54e-08 | 186 | 175 | 9 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.61e-08 | 193 | 175 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.56e-07 | 186 | 175 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-06 | 198 | 175 | 8 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-06 | 198 | 175 | 8 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-06 | 198 | 175 | 8 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-06 | 198 | 175 | 8 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-06 | 171 | 175 | 7 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 177 | 175 | 7 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 177 | 175 | 7 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 177 | 175 | 7 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-06 | 182 | 175 | 7 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | Club_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 8.04e-06 | 120 | 175 | 6 | 7f85208f0455f3e634f8e7e81beea60b4ef1d2a5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-06 | 183 | 175 | 7 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.16e-06 | 183 | 175 | 7 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-06 | 183 | 175 | 7 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.45e-06 | 184 | 175 | 7 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.45e-06 | 184 | 175 | 7 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 8.45e-06 | 184 | 175 | 7 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 184 | 175 | 7 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.07e-06 | 186 | 175 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.39e-06 | 187 | 175 | 7 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.73e-06 | 188 | 175 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.73e-06 | 188 | 175 | 7 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 191 | 175 | 7 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 191 | 175 | 7 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.27e-05 | 196 | 175 | 7 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.32e-05 | 197 | 175 | 7 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-05 | 200 | 175 | 7 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-05 | 200 | 175 | 7 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.45e-05 | 200 | 175 | 7 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | TCGA-Skin|World / Sample_Type by Project: Shred V9 | 1.94e-05 | 140 | 175 | 6 | 57d9979bfdcb695869690bf62fa80759ad06eb6c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 157 | 175 | 6 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 157 | 175 | 6 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.83e-05 | 158 | 175 | 6 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 162 | 175 | 6 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 162 | 175 | 6 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-05 | 163 | 175 | 6 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-05 | 163 | 175 | 6 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 4.71e-05 | 164 | 175 | 6 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 4.71e-05 | 164 | 175 | 6 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.39e-05 | 168 | 175 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.57e-05 | 169 | 175 | 6 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.57e-05 | 169 | 175 | 6 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.94e-05 | 171 | 175 | 6 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.54e-05 | 174 | 175 | 6 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.54e-05 | 174 | 175 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.54e-05 | 174 | 175 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.75e-05 | 175 | 175 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.75e-05 | 175 | 175 | 6 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.75e-05 | 175 | 175 | 6 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.75e-05 | 175 | 175 | 6 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 6.75e-05 | 175 | 175 | 6 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | 356C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.19e-05 | 177 | 175 | 6 | 7ddd7d1854ad42abd630ad0c702105102cec93e7 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.19e-05 | 177 | 175 | 6 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 7.42e-05 | 178 | 175 | 6 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | Control-Myeloid-pDC|World / Disease state, Lineage and Cell class | 7.42e-05 | 178 | 175 | 6 | 20ef63d925e67ddd5955832312ca8574a6f838a4 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 7.89e-05 | 180 | 175 | 6 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 180 | 175 | 6 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 180 | 175 | 6 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 180 | 175 | 6 | cedbe692c5257fb6f9a552e2f197163626ac17d9 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.13e-05 | 181 | 175 | 6 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-05 | 181 | 175 | 6 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 8.38e-05 | 182 | 175 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-05 | 182 | 175 | 6 | 812ff2a50a510b18d865e89465dba1754a08ef61 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 8.64e-05 | 183 | 175 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 183 | 175 | 6 | 876b4f128c2168fdae7488201ff44f19c06c8415 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 183 | 175 | 6 | b190b650e61b1b20baf5e42d04acac82d3fd1400 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 8.64e-05 | 183 | 175 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 8.64e-05 | 183 | 175 | 6 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.64e-05 | 183 | 175 | 6 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.64e-05 | 183 | 175 | 6 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 183 | 175 | 6 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 9.17e-05 | 185 | 175 | 6 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 9.17e-05 | 185 | 175 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.17e-05 | 185 | 175 | 6 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 9.17e-05 | 185 | 175 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.17e-05 | 185 | 175 | 6 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-05 | 186 | 175 | 6 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.45e-05 | 186 | 175 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.45e-05 | 186 | 175 | 6 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-05 | 186 | 175 | 6 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.45e-05 | 186 | 175 | 6 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.45e-05 | 186 | 175 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.73e-05 | 187 | 175 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-04 | 188 | 175 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.00e-04 | 188 | 175 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.00e-04 | 188 | 175 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.03e-04 | 189 | 175 | 6 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-04 | 189 | 175 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 1.03e-04 | 189 | 175 | 6 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-04 | 190 | 175 | 6 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 1.09e-04 | 191 | 175 | 6 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 1.09e-04 | 191 | 175 | 6 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 191 | 175 | 6 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.12e-04 | 192 | 175 | 6 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 192 | 175 | 6 | 32e4a180037e516c5cc798cd9dada9385e0f43ae | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A | SIPA1L3 SREBF1 THTPA HDAC7 NR2F1 GAB2 NALF1 MARF1 ORAI3 PPP6R2 AP3D1 EPHA1 | 3.56e-08 | 197 | 172 | 12 | 1909_UP |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.78e-06 | 198 | 172 | 10 | 1538_UP | |
| Drug | chrysene | ATP6V0A1 ARHGAP23 HLA-DOA NOXA1 MUC16 HEATR1 CBFA2T3 LPIN1 MDN1 PLEKHG6 PTPRZ1 CPT1C KANK4 COBL SDF4 SMPD3 AGBL2 NOTCH1 EPHA1 REV1 | 1.01e-05 | 871 | 172 | 20 | ctd:C031180 |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.25e-05 | 186 | 172 | 9 | 6793_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | NR2C1 PPFIA1 RAB11FIP2 MFSD12 SLC7A1 LNPEP ATAD2B PARD3 EP300 | 1.68e-05 | 193 | 172 | 9 | 6967_DN |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.75e-05 | 194 | 172 | 9 | 5696_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.90e-05 | 196 | 172 | 9 | 3187_DN | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.90e-05 | 196 | 172 | 9 | 2847_UP | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.97e-05 | 197 | 172 | 9 | 3212_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.06e-05 | 198 | 172 | 9 | 7016_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.23e-05 | 200 | 172 | 9 | 3322_UP | |
| Disease | Waardenburg syndrome type 1 (implicated_via_orthology) | 3.22e-05 | 2 | 168 | 2 | DOID:0110948 (implicated_via_orthology) | |
| Disease | lipid storage disease (biomarker_via_orthology) | 3.22e-05 | 2 | 168 | 2 | DOID:9455 (biomarker_via_orthology) | |
| Disease | cutaneous melanoma | 6.97e-05 | 121 | 168 | 6 | EFO_0000389 | |
| Disease | hair color | 7.82e-05 | 311 | 168 | 9 | EFO_0003924 | |
| Disease | diet measurement, HOMA-B | 1.64e-04 | 19 | 168 | 3 | EFO_0004469, EFO_0008111 | |
| Disease | Adenocarcinoma of large intestine | 2.27e-04 | 96 | 168 | 5 | C1319315 | |
| Disease | suntan | 3.15e-04 | 103 | 168 | 5 | EFO_0004279 | |
| Disease | facial pigmentation measurement | 3.17e-04 | 57 | 168 | 4 | EFO_0006942 | |
| Disease | Waardenburg syndrome (is_implicated_in) | 3.19e-04 | 5 | 168 | 2 | DOID:9258 (is_implicated_in) | |
| Disease | Clear cell sarcoma of kidney | 4.76e-04 | 6 | 168 | 2 | C0334488 | |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 4.76e-04 | 6 | 168 | 2 | DOID:11722 (implicated_via_orthology) | |
| Disease | Waardenburg Syndrome | 4.76e-04 | 6 | 168 | 2 | C3266898 | |
| Disease | melanoma | 5.71e-04 | 248 | 168 | 7 | C0025202 | |
| Disease | skin aging measurement | 6.16e-04 | 181 | 168 | 6 | EFO_0008006 | |
| Disease | susceptibility to mononucleosis measurement | 6.57e-04 | 69 | 168 | 4 | EFO_0008403 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 6.64e-04 | 7 | 168 | 2 | EFO_0020797 | |
| Disease | Albinism, Oculocutaneous | 6.64e-04 | 7 | 168 | 2 | C0078918 | |
| Disease | melanoma | 7.90e-04 | 126 | 168 | 5 | EFO_0000756 | |
| Disease | heart conduction disease (implicated_via_orthology) | 7.96e-04 | 32 | 168 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | menstrual cycle measurement | 8.82e-04 | 8 | 168 | 2 | EFO_0007786 | |
| Disease | Congenital Hand Deformities | 8.82e-04 | 8 | 168 | 2 | C0018566 | |
| Disease | Malignant neoplasm of breast | NCOA6 RAPH1 SREBF2 OCA2 SIX4 HDAC7 NR2F1 KCNT2 CSNK1D MROH7 DIO3 ATM EP300 NOTCH1 TP53BP1 | 1.28e-03 | 1074 | 168 | 15 | C0006142 |
| Disease | coronary artery disease | ZHX3 NR2C1 NCOA6 HCN4 PPFIA1 HECTD4 SREBF1 USP43 TFAP2B KIAA0319 DOCK5 LNPEP MITF BSN TBX20 SLC2A12 | 1.36e-03 | 1194 | 168 | 16 | EFO_0001645 |
| Disease | Giant Cell Glioblastoma | 1.37e-03 | 84 | 168 | 4 | C0334588 | |
| Disease | diabetes mellitus biomarker | 1.41e-03 | 10 | 168 | 2 | EFO_0006842 | |
| Disease | alopecia areata (is_marker_for) | 1.41e-03 | 10 | 168 | 2 | DOID:986 (is_marker_for) | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.41e-03 | 10 | 168 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | obesity (implicated_via_orthology) | 1.50e-03 | 215 | 168 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.50e-03 | 86 | 168 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | resting heart rate | 1.67e-03 | 149 | 168 | 5 | EFO_0004351 | |
| Disease | N-acetylhistidine measurement | 1.71e-03 | 11 | 168 | 2 | EFO_0800022 | |
| Disease | free cholesterol to total lipids in IDL percentage | 1.89e-03 | 43 | 168 | 3 | EFO_0022278 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 2.05e-03 | 12 | 168 | 2 | EFO_0800453 | |
| Disease | putamen volume change measurement | 2.41e-03 | 13 | 168 | 2 | EFO_0021495 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 2.41e-03 | 13 | 168 | 2 | OBA_2045082 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.51e-03 | 99 | 168 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | Adenoid Cystic Carcinoma | 2.60e-03 | 100 | 168 | 4 | C0010606 | |
| Disease | uric acid measurement | CDC42BPG ZHX3 COBLL1 SIPA1L3 HECTD4 TFAP2B MFSD12 KIAA0319 ANKRD28 SLC27A5 | 2.70e-03 | 610 | 168 | 10 | EFO_0004761 |
| Disease | chromosome-type aberration frequency | 2.80e-03 | 14 | 168 | 2 | EFO_0009861 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.22e-03 | 15 | 168 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.22e-03 | 15 | 168 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.22e-03 | 15 | 168 | 2 | C0154091 | |
| Disease | QT interval | 3.65e-03 | 534 | 168 | 9 | EFO_0004682 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 3.67e-03 | 16 | 168 | 2 | EFO_0004792, HP_0002140 | |
| Disease | T-Cell Lymphoma | 3.67e-03 | 16 | 168 | 2 | C0079772 | |
| Disease | gliosarcoma | 3.67e-03 | 16 | 168 | 2 | C0206726 | |
| Disease | response to hydrochlorothiazide, systolic blood pressure change measurement | 3.67e-03 | 16 | 168 | 2 | EFO_0005202, EFO_0006944 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 3.67e-03 | 16 | 168 | 2 | C0334634 | |
| Disease | Glioblastoma Multiforme | 3.79e-03 | 111 | 168 | 4 | C1621958 | |
| Disease | leukemia | 3.83e-03 | 55 | 168 | 3 | C0023418 | |
| Disease | triglycerides in large VLDL measurement | 4.03e-03 | 56 | 168 | 3 | EFO_0022178 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 4.03e-03 | 56 | 168 | 3 | EFO_0022251 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.14e-03 | 264 | 168 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | non-melanoma skin carcinoma | 4.22e-03 | 265 | 168 | 6 | EFO_0009260 | |
| Disease | carotid artery intima media thickness | 4.40e-03 | 450 | 168 | 8 | EFO_0007117 | |
| Disease | cortical surface area measurement | ZHX3 RAPH1 PPFIA1 SREBF1 TFAP2B NR2F1 TUFM NOL4L NALF1 ATAD2B NAV2 PAX3 TACC3 PARD3 KDM1A AGAP1 | 4.40e-03 | 1345 | 168 | 16 | EFO_0010736 |
| Disease | macula measurement | 4.63e-03 | 189 | 168 | 5 | EFO_0008375 | |
| Disease | Carcinoma of bladder | 4.64e-03 | 18 | 168 | 2 | C0699885 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 4.64e-03 | 18 | 168 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | triglycerides in VLDL measurement | 4.67e-03 | 59 | 168 | 3 | EFO_0022326 | |
| Disease | creatinine measurement | PDE7A SIPA1L3 GAB2 CELSR3 ALMS1 ZNF592 SCMH1 CSPG4 MITF BSN PARD3 MUSK OPLAH | 4.70e-03 | 995 | 168 | 13 | EFO_0004518 |
| Disease | free cholesterol in very large VLDL measurement | 5.12e-03 | 61 | 168 | 3 | EFO_0022274 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.14e-03 | 121 | 168 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | skin sensitivity to sun | 5.17e-03 | 19 | 168 | 2 | EFO_0004795 | |
| Disease | lysophosphatidylcholine 20:5 measurement | 5.17e-03 | 19 | 168 | 2 | EFO_0010364 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 5.17e-03 | 19 | 168 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 5.17e-03 | 19 | 168 | 2 | C2936783 | |
| Disease | hematocrit | RALGAPA1 RAPH1 COBLL1 HECTD4 SREBF1 TFAP2B ADGRG6 MITF ORAI3 BSN AP3D1 MUSK TP53BP1 | 5.35e-03 | 1011 | 168 | 13 | EFO_0004348 |
| Disease | triglycerides in medium LDL measurement | 5.36e-03 | 62 | 168 | 3 | EFO_0022322 | |
| Disease | total lipids in very large VLDL measurement | 5.36e-03 | 62 | 168 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 5.36e-03 | 62 | 168 | 3 | EFO_0022299 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMLLDGLASSHPVSQ | 496 | Q9UKU6 | |
| SLERNGARAPSHMSS | 166 | Q9Y2J4 | |
| LRSSGSLGHRPSQEM | 461 | Q5SW79 | |
| GVQTPSLLSDSMLHS | 521 | Q09472 | |
| SMGHAESLSGLSLRL | 441 | P21709 | |
| PGTMTRNLGLDSHFL | 366 | Q96LX7 | |
| GHTSRVLSLTMSPDG | 441 | Q12834 | |
| LAANGTTDMHTSVPR | 236 | Q9Y6F7 | |
| GPSHSSESLREFMRQ | 631 | A0A096LP49 | |
| NGLSKDMSSLHISPN | 426 | Q9UPQ3 | |
| LMDASARPANHSSTR | 31 | Q9BRK5 | |
| HRSTGLRLAQGSAMP | 666 | Q6UVK1 | |
| GHSEMAELSLTNISP | 981 | Q68DQ2 | |
| PSNIRMATHTLITGL | 801 | P46379 | |
| NTPTADGHLLTLMST | 611 | Q8IZF6 | |
| MDLSAASHRIPLSDG | 1 | P51857 | |
| THFGVLMDLPRSASQ | 841 | Q86SQ4 | |
| NHTLISMGRPSSTLG | 2841 | Q8TCU4 | |
| MLSDSDNRATISPLH | 541 | O15084 | |
| MAASPHTLSSRLLTG | 1 | Q12887 | |
| SHLMHSSLPGLTRLE | 1516 | Q8TDJ6 | |
| AAGHQPLSTMTVRSR | 386 | Q8IYM0 | |
| NGRSRLSHSMSPDAQ | 1111 | Q53SF7 | |
| DPSDLHSRKNMLLAT | 346 | Q92481 | |
| VLISLSSGMPNHSAS | 286 | O14617 | |
| LTQLSHTQPTLGMRE | 486 | Q68CQ1 | |
| FLTKGRSHSSLPQMS | 71 | Q04671 | |
| QLMRGEPFASHSLVS | 206 | Q96IZ5 | |
| HGSLSSRMSRAEPTA | 1181 | Q70E73 | |
| ALDCSSSIRQPSLHM | 206 | O94776 | |
| GPLLSDSHVAFRLTM | 366 | P13056 | |
| DARSLIMDSPRAGTH | 231 | Q86UR1 | |
| RLSQSGHMLLSLSRG | 351 | Q99666 | |
| RLSQSGHMLLSLSRG | 351 | O14715 | |
| QSLGLAAMSSGTHRL | 21 | Q9H0N5 | |
| LLAAAGLHASPMSAD | 276 | P10589 | |
| PDSMASAASALHLLS | 766 | Q6P2E9 | |
| LNHLLESMPLREGSS | 126 | Q96HZ4 | |
| ISSHSRSSLMPLRND | 411 | Q8TD20 | |
| HSFSEALRRPASMGS | 1481 | Q6DT37 | |
| HLRDSARKPGALSMS | 701 | Q9NPG4 | |
| LDLMGASQHSLRALS | 36 | Q9BRQ5 | |
| RSHSDELLQSMGSSP | 786 | Q8N1W1 | |
| SLHSRSPSISNMAAL | 336 | Q9H1A4 | |
| NMAALSRAHSPALGV | 346 | Q9H1A4 | |
| LPESTSRGMTHSEQR | 86 | Q8WXI7 | |
| SRGMTHSEQRTSPSL | 91 | Q8WXI7 | |
| TMHLATSRTPASLSG | 13456 | Q8WXI7 | |
| RSPISHEGSLSSAAM | 3236 | Q96JQ0 | |
| LLDHISSPSLALMAG | 116 | Q01851 | |
| SLHSSMVGADRLGTL | 3421 | Q9NU22 | |
| MVGPLHSSLAASALS | 2346 | P46531 | |
| LSDSGRNSMSSLPTH | 171 | Q9Y250 | |
| MTLAPGHAALETQTL | 46 | Q8N307 | |
| LQALTLGRHALMSGT | 386 | Q2TV78 | |
| SGPAATMLRSLLLHS | 21 | P55073 | |
| VPASQRAVMSSGHAL | 661 | Q9ULI0 | |
| RTGNTVATDMLSEHP | 2326 | Q2LD37 | |
| GAMHPLRSGLLNSTS | 306 | Q12809 | |
| VLHRGLPSSASDMSL | 2526 | Q9UPA5 | |
| ASLLHATGMTLAFPA | 46 | Q9P2D6 | |
| SAGSLQSLADAMHIP | 101 | O43424 | |
| QAHSALSQRPPMLSS | 1941 | A6NKB5 | |
| SAHQSRSRMLELSAP | 641 | P29122 | |
| EALSLMHPSISFSLR | 176 | Q9UHC1 | |
| MHPSISFSLRNDVSG | 181 | Q9UHC1 | |
| SGLFSHLPLESRQQM | 296 | Q13946 | |
| ILSASDMLHSPLSSL | 546 | Q6NT32 | |
| MRLHRGAPVNISSSD | 371 | P48730 | |
| MRATHGSNSLPSSAR | 1246 | Q8TDM6 | |
| MHLATSPILSEGASR | 101 | Q14693 | |
| LLSPSGQADAHTLAM | 616 | Q13136 | |
| LHPNLTSMTFRGSVT | 181 | Q9UIQ6 | |
| MAAATLLRATPHFSG | 1 | P49411 | |
| SSDQSDHPLLRRKSM | 1001 | Q6UVM3 | |
| DPMLSTHTQLTGTIA | 816 | Q9NQV6 | |
| LMPLLKLSGSDTHTN | 181 | O60431 | |
| LRSPHMNLSGTAESL | 546 | P23471 | |
| ESQASTLRPASPLMH | 551 | Q96FC9 | |
| MLLPQEGSLSIHTSL | 1826 | Q9Y4D8 | |
| PHLASSLSPSQDERM | 11 | Q96MY1 | |
| SMSQTHPVLESGLLA | 21 | O75081 | |
| TQLSGLTDHLPVAMR | 631 | Q9NY59 | |
| SRTMPLLSLHSRGGS | 31 | P54368 | |
| PNASEAHLAMGRTLS | 146 | P78563 | |
| ASLRDHSTPETLSIM | 926 | Q9C091 | |
| SDHLDTPMLRSGNLK | 771 | P16144 | |
| MTPILEGSHRAHSLL | 431 | Q8IZ21 | |
| LRRASPHSSGESMAA | 1101 | Q9Y3Q4 | |
| RLSALAASGTHLPQM | 136 | Q99853 | |
| QRLDHMKSLDSLPTS | 431 | P23760 | |
| ATLGETHRLFPNTML | 361 | P04062 | |
| ASQSDAMDPLLSGLH | 211 | Q14686 | |
| GMTTRSLNTHDVAAP | 406 | Q9Y6A1 | |
| TSPMLGVASEHTRQL | 396 | Q3KR16 | |
| FFRMGTHSRNSLLSP | 341 | Q8TCG5 | |
| ELLMTLHEPANSSAS | 1346 | Q13315 | |
| GAAFQSRLPHDRMTS | 176 | O60341 | |
| FHTLMTLLSPQEAGA | 11 | P06340 | |
| SLQLMDNRLSPFHGS | 1766 | Q9H7D0 | |
| LAHVARTRLTPSMAG | 351 | Q8IVS8 | |
| LGSPLTELSMHQDLS | 396 | Q2WGN9 | |
| SGTPDVARAMTHTLL | 421 | Q6P531 | |
| SMHSRSLTLGPSLSL | 271 | O75128 | |
| GITDSHMLSLPHLRS | 131 | Q5U5Z8 | |
| HSAASAMALQPGTLQ | 251 | Q9NUK0 | |
| MKSRLSSLSLSPANH | 1561 | Q9Y4F3 | |
| RSEPSHGSLRISNAM | 346 | Q8NA82 | |
| HGSLRISNAMEPATE | 351 | Q8NA82 | |
| ALRGLSSLSIHLGME | 36 | Q96RR4 | |
| RASSMPATLLHSRAS | 161 | Q5T7N3 | |
| MATHGLLSSDAPRRI | 296 | O60256 | |
| LADSDTSLMLSLNHP | 476 | Q9H583 | |
| QSLMTTERLSGSGLH | 336 | Q8WUI4 | |
| QDHGSPRLSATTMVA | 406 | Q9NYQ7 | |
| SSLIGHLQTLSPDMQ | 336 | Q16690 | |
| SLAMTADLIGPHTNS | 386 | Q6NUT3 | |
| AALMATHQPLSLSRT | 426 | Q9UJU5 | |
| GARLMAALLHTNTPS | 346 | O75170 | |
| DNARSSLSASHPMVG | 216 | Q8TEW0 | |
| TIMASQRHLSSEPLS | 76 | P03905 | |
| DLGTPRLTTHLNMTV | 426 | Q9UN66 | |
| GSCLMAEALHRTSPT | 41 | A6NNL0 | |
| GSCLMAEALHRTSPT | 41 | B1AL46 | |
| RMLTTPNHTSLSILG | 561 | Q9BTC8 | |
| TLPAMDNSRLHRASS | 391 | Q9UQC2 | |
| KERPHMLNLSGTDSS | 1056 | Q5VT97 | |
| STAPTNHLVAGRAMT | 301 | Q9Y6A5 | |
| RRLGHDAQPMTSLDT | 411 | Q8N2I9 | |
| SPTGHSLKSLDLLTM | 166 | Q6ZU15 | |
| PTFTHRQMLGSTELR | 656 | Q15572 | |
| DQPLDSSHIASIRMG | 66 | O14841 | |
| THTGLPIMASLANTA | 46 | Q8NET5 | |
| ISLALRSHMSKAPSN | 841 | Q96Q15 | |
| ASPRQSMGLSQHSLN | 1976 | Q8IVL1 | |
| MASLTASRAHSLGGL | 381 | O60292 | |
| SDGITNLSLSSHMEP | 316 | Q9UIU6 | |
| SGLPRTAISELHGNM | 176 | Q9NRC8 | |
| RPSMANEKHLALSSS | 266 | Q68D10 | |
| GNSLARSLEPHSDSM | 496 | Q96GD3 | |
| TARLMAGASPTRTHQ | 1041 | P36956 | |
| LSILQMDRGDPQHSS | 16 | Q8WZ69 | |
| SSHGDLRPRASALAM | 21 | Q6IPW1 | |
| PTNQASVSSMLLEGH | 1066 | Q96JI7 | |
| PSLESLLAAGSHMLR | 1416 | O15417 | |
| LGQIRSSTMSNPDHF | 186 | Q8WWB5 | |
| LVSVEAQSSPGLHMR | 771 | Q15468 | |
| SGLNMAPHVAQRSTS | 611 | Q70EL4 | |
| ARALLQTASSLAPHM | 476 | Q8TAM2 | |
| GLSEPTSFMLSLSHQ | 1621 | Q6GYQ0 | |
| EMQARAHGLSLIPST | 396 | O75030 | |
| VTDTGDMSVLNSPRH | 401 | Q9UBZ9 | |
| MPLAHSVLSSGARVL | 211 | Q9Y2P5 | |
| AGIPSMSTRDLHSTV | 141 | Q9NXZ1 | |
| EFSRTHMTLNAPGVL | 146 | P30825 | |
| GRTTMALDLPSSHLQ | 991 | A6NE52 | |
| ARAHLDNSSLGMSQP | 236 | Q9P227 | |
| SLMHGIRNPDLSQTS | 1066 | Q92610 | |
| LMAGASPTRTHQLLE | 1041 | Q12772 | |
| HRLSSMLGVPAQETA | 176 | Q9BU02 | |
| EMSSLPVRSHSSLSL | 21 | Q8N8P6 | |
| SRRGPDLSMNLDRSH | 431 | Q9UJT2 | |
| LLGPQRLSSAHSMSD | 216 | Q7L804 | |
| SGSHFSMLSRHLPNL | 36 | Q12888 | |
| TEHSGSTVPSILNRM | 341 | Q93050 | |
| MATALVSAHSLAPLN | 1 | Q16670 | |
| AASPMAATTHRTLEL | 451 | Q8N398 | |
| ISQMGIRSSIAHSSP | 186 | Q96NM4 | |
| GNLSAEPTTRRHMAA | 456 | Q9H892 | |
| LLSPMNLLSLHTASG | 146 | Q9NYA1 | |
| PALLASTQESMGLHR | 1361 | Q9H7P9 | |
| ALLSDLETTTSHMPR | 6 | O43294 | |
| AAIQGLRHSSAVMTP | 431 | Q9UMR3 | |
| DPGNHLINMTSSTTL | 146 | Q14139 | |
| LGGSSSSMAVHLLQA | 456 | P0DP72 | |
| NGSLEMPSSHILAER | 706 | Q9H4I2 | |
| LSGSIRMNSSPLFLH | 291 | Q63HR2 | |
| MVSHGSSPSLLEALS | 1 | Q9BRZ2 | |
| SSPNIMLLHRDSGIL | 581 | Q8NI36 | |
| RLSSTGHSMTPQSDL | 166 | Q9NR64 | |
| SNSSGKEVLMPSHSL | 261 | Q5VV43 | |
| LLASMGESSPAAQAH | 106 | B1AL88 | |
| GDLNEFLRSMSPHTV | 661 | O15146 | |
| HLDNSAMGQSPLSAV | 291 | P52961 |